Atara Biotherapeutics, Inc. (ATRA) NASDAQ
9.90
-0.38(-3.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 226.92M |
| Enterprise Value | 271.24M |
| P/E Ratio | -14.73 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 3.85 |
| Price/Book Ratio | -3.74 |
| Enterprise/Revenue | 3.89 |
| Enterprise/EBITDA | -16.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.41 |
| Operating Margin | -0.27 |
Management Effectiveness
| Return On Assets | -0.47 |
| Return On Equity | 0.26 |
Income Statement
| Revenue | 120.77M |
| Revenue/Share | 1.64 |
| Gross Profit | 99.56M |
| EBITDA | 38.63M |
| Net Income | 32.69M |
| Diluted EPS | 2.57 |
Balance Sheet
| Total Cash | 8.36M |
| Total Cash/Share | 0.59 |
| Total Debt | 9.08M |
| Total Debt/Equity | -0.24 |
| Current Ratio | 2.16 |
| Book Value Per Share | -2.65 |
Price History
| 52-Week Change | 23.75 |
| 52-Week High | 19.15 |
| 52-Week Low | 3.92 |
| Moving Average 50 Days | 6.56 |
| Moving Average 200 Days | 10.13 |
Statistics
| Average Volume | 1.53M |
| Shares Outstanding | 9.01M |
| % Held by Institutions | 20.44 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 20, 2024 |
